Marina Chiara Garassino to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Marina Chiara Garassino has written about Dose-Response Relationship, Drug.
Connection Strength
0.109
-
Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patients. PLoS One. 2013; 8(4):e59981.
Score: 0.084
-
Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells. Oncotarget. 2015 Oct 06; 6(30):30072-87.
Score: 0.025